News & Events

HTG Molecular to Present Corporate Overview at the SVB Leerink 9th Annual Global Healthcare Conference

TUCSON, Ariz. , Feb. 19, 2020 (GLOBE NEWSWIRE) – HTG Molecular Diagnostics , Inc. (Nasdaq: HTGM) (HTG), a life science company whose mission is to advance precision medicine, today announced that John Lubniewski , President and CEO, will present a corporate overview at the SVB Leerink 9 th Annual

full press release

Posted on:

Return To List

Page last updated